Find Academic Supervisors

• Cardiology
• Emergency Medicine
• Critical Care
• +5 more

Sebastian Christoph Wiberg serves as a Clinical Associate Professor within the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, based at Rigshospitalet (Copenhagen University Hospital). His research bridges clinical cardiology, emergency medicine, and critical care, with emphasis on resuscitation science and translational applications. His scholarly focus centers on optimizing cardiac arrest outcomes through innovative approaches: validating prognostic biomarkers like neurofilament light chain, refining post-resuscitation care protocols (e.g., blood pressure targets), and implementing public health initiatives such as nationwide CPR training in schools. He actively explores AI integration in perioperative settings through the TRIPLE-A Database project and investigates therapeutic interventions for conditions ranging from myocardial infarction to pulmonary embolism using rigorous clinical trial methodologies. Analysis of his 2024-2025 publications reveals a cohesive research trajectory centered on evidence-based emergency cardiovascular care. Key themes include biomarker-driven prognostication, Bayesian statistical approaches to trial data, and registry-based epidemiology—particularly through Danish national databases. His work consistently targets clinically actionable improvements in out-of-hospital cardiac arrest management and acute cardiovascular interventions. No formal scientific awards were documented in source materials, though his publications have generated academic engagement via social media (X/Bluesky) and platforms like Mendeley. While student supervision details are absent from available records, his collaborative framework includes major consortia such as the Danish Cardiac Arrest Group and TRIPLE-A Collaborator Group, which facilitate multi-center data collection across Eastern Denmark's healthcare system. Dr. Wiberg contributes to advancing perioperative safety through the TRIPLE-A Database—a comprehensive platform tracking anesthesia outcomes since 2017—and participates in nationwide initiatives like the mandated school CPR training program, demonstrating commitment to both technological innovation and public health implementation.

Vincent LamView profile

Professor

• Hepatobiliary Surgery
• Pancreatic Surgery
• Robotic Surgery
• +4 more

Professor Vincent Lam is the Professor of Surgery and Head of the Department of Clinical Medicine at Macquarie University. He is a consultant Hepatobiliary, Pancreatic, and Transplant surgeon at Westmead Hospital, holding leadership roles in surgical training and professional organizations. His clinical expertise spans minimally invasive surgery, robotic hepatobiliary procedures, and surgical management of liver, pancreatic, and bile duct cancers. Education: MBBS (University of Sydney, 1999), MS (2006), DClinSurg (2013). Research focuses on hepatocellular carcinoma (HCC) prognosis, surgical outcomes, and translational oncology. He leads projects like the Fred Stephens Fellowship in Colorectal Surgery (2021–2030). Research Interests: Optimizing surgical techniques for liver/pancreatic cancers, developing prognostic models (e.g., TBS-based scores), and investigating biomarkers for recurrence prediction. Key contributions include the Australia-first robotic cholecystectomy (2014) and machine learning models for postoperative complications. Awarded the 1992 Australian Students Prize for Excellence. Active in surgical education, serving as Deputy Chair of the Medical Staff Council at Westmead Hospital and training supervisor for the NSW General Surgery Board.

Hans NijmanView profile

Professor

• Gynecologic Oncology
• Tumor Immunology
• Immunotherapy
• +3 more

Prof. Dr. Hans W. Nijman is a Professor of Gynecologic Oncology and Immunotherapy at the University of Groningen, Netherlands, and heads the Department of Obstetrics and Gynecology at the University Medical Center Groningen (UMCG). He specializes in translational and clinical research focused on tumor immunology, with a particular emphasis on gynecologic cancers. His work includes developing immunotherapeutic strategies and optimizing cancer networks for equitable patient care. Education & Positions: Trained in Obstetrics & Gynecology (1995–2000) with a PhD in Immunology (1995), followed by a gynecologic oncology fellowship in Toronto (2001–2002). Appointed as a professor in 2008 and department head in 2015. Additional roles include director of Clinical Research at Vicinivax and advisory roles for pharmaceutical companies. Research Interests: His research bridges tumor immunology and clinical oncology, focusing on biomarkers, therapeutic vaccines (e.g., HPV16-based vaccines), and immunotherapy response mechanisms. Key areas include granulosa cell tumors, cervical cancer management, and molecular pathology of endometrial carcinoma. Grants & Collaborations: Secured funding from Dutch Cancer Society (KWF), European Research Council (ERC), and Health Holland. Collaborates with institutions like Vicinivax and BioNTech on vaccine development and clinical trials. Labs & Teams: Leads the Onco-Immunology (O-I) and Translational Immunology Groningen (TRIGR) groups at UMCG, focusing on immunotherapeutic innovation for gynecologic malignancies.

• Hepatology
• Liver Cancer
• Transplant Hepatology
• +5 more

Ariel Jaffe, MD, is an Assistant Professor of Medicine (Digestive Diseases) and Medical Director of Liver Transplant Oncology at Yale School of Medicine. She specializes in hepatology, liver cancer, and transplant hepatology, with a focus on improving outcomes for patients with hepatocellular carcinoma (HCC) and metabolic-associated liver disease. Her clinical practice spans locations in New Haven, Waterford, and Stamford, CT, integrating care across the Smilow Liver Cancer Program and Liver Transplant Program. Dr. Jaffe’s research emphasizes clinical workflow optimization, prognostic biomarkers, and the application of artificial intelligence in diagnostics. She has pioneered studies on imaging biomarkers for immunotherapy response, automated prognostic assessment via machine learning, and community-level factors influencing HCC outcomes. Her work bridges clinical care and innovation, with a focus on holistic patient management and translational research. Education : MD from Eastern Virginia Medical School (2014); Residency at New York Presbyterian–Columbia University Medical Center (2017); Fellowship in Gastroenterology and Transplant Hepatology at Yale University. Key Research Themes : Impact of metabolic syndrome on liver cancer progression Immunotherapy in pre- and post-transplant HCC patients AI-driven radiomics for treatment decision-making Awards : Recognized by the American Liver Foundation and honored for academic excellence during medical training. Dr. Jaffe collaborates with interdisciplinary teams including radiologists, oncologists, and surgeons. She leads studies funded by NIH and industry partnerships, focusing on clinical trial design, biomarker discovery, and health equity in liver disease management.

Thor EdvardsenView profile

Professor

• Cardiovascular Imaging
• Cardiology
• Echocardiography
• +4 more

Thor Edvardsen is a Professor II in the Department of Cardiology at the University of Oslo’s Faculty of Medicine. He serves as President of the European Association of Cardiovascular Imaging (EACVI, 2018–2020) and directs the Center for Cardiological Innovation, a Center for Research-based Innovation funded by the Norwegian Research Council (2011–2019). His roles include editorial board memberships for journals like European Heart Journal – Cardiovascular Imaging and JACC Imaging . Research interests focus on echocardiography, cardiac imaging technologies, myocardial function, and clinical applications in cardiovascular disease. Notable contributions include studies on left ventricular strain analysis, artificial intelligence in imaging, and outcomes after transcatheter aortic valve implantation (TAVI). Recent articles highlight advancements in deep learning for strain measurements, risk stratification via echocardiography, and mechanisms of arrhythmias in hypertrophic cardiomyopathy. His work bridges clinical practice and innovation, with a focus on improving diagnostic accuracy and patient outcomes. Thor Edvardsen leads the Center for Cardiological Innovation, driving multidisciplinary research in cardiovascular imaging and device development. His research also addresses exercise-cardiac interactions in athletes and the impact of anabolic-androgenic steroids on myocardial pathology.

• Coronary Artery
• Coronary Angiography
• Troponin
• +5 more

Jonathan Spiro is a Clinical Associate Professor at the UWA Medical School, The University of Western Australia, specializing in Internal Medicine with research focused on coronary artery diagnostics and acute cardiac syndromes. His expertise spans coronary vasomotor disorders, myocardial infarction with non-obstructive coronary arteries (MINOCA), cardiac magnetic resonance imaging, and high-sensitivity troponin applications in emergency settings. He investigates diagnostic protocols for coronary angiography and functional testing in non-obstructive disease, contributing to UN Sustainable Development Goals in health and well-being. Recent publications (2024-2025) emphasize cardiac MRI in MINOCA, CT angiography-based likelihood models, and nationwide variations in functional coronary angiography protocols across Australia/New Zealand, highlighting clinical translation and diagnostic refinement. Dr. Spiro leads three active MicroSTREAM projects (ANOCA, ACS, CTO) at Royal Perth Hospital (2025-2027) investigating coronary syndromes through multicenter collaborations involving 13 co-investigators, aiming to advance diagnostic pathways and therapeutic strategies for coronary artery conditions.

Edmond KwanView profile

Academic

• Prostate Cancer Genomics
• Epigenomics
• Circulating Tumour DNA (ctDNA) Biomarkers
• +5 more

Edmond Kwan is a Senior Research Fellow and Laboratory Head at Eastern Health Clinical School, Monash University, with a cross-appointment in the Biomedicine Discovery Institute's Prostate Cancer Research Group. He is also a clinician-scientist and genitourinary cancer medical oncologist at Eastern Health, Melbourne. Kwan holds dual expertise in prostate cancer genomics and clinical oncology, focusing on developing biomarkers (tissue/ctDNA) to predict treatment outcomes in metastatic prostate cancer. His work integrates molecular biology, bioinformatics, and clinical trials to guide precision medicine strategies. Education & Career: PhD in Prostate Cancer Genomics (Monash University) Postdoctoral Fellowship at Vancouver Prostate Centre (2017–2024) Genitourinary Clinical Fellowship at BC Cancer, Canada Returned to Australia in 2024 to establish independent research Research Interests: Prostate cancer genomics, ctDNA biomarkers, precision medicine, biobanking, and translational oncology. His team explores genomic/epigenomic alterations in tumor tissue and blood to improve therapeutic decision-making. Key Projects: TheraP Trial (Phase 2 trial comparing Lu-PSMA-617 with cabazitaxel) ICE-PAC Trial (Avelumab + SABR for mCRPC) Monash Cancer Donor Program (Biobanking initiatives) Grants & Collaborations: Principal Investigator on multiple ANZUP-funded projects (e.g., immune checkpoint inhibitor biomarker studies, PARP inhibitor trials). Collaborates with institutions in Australia, Canada, and internationally on genomic profiling and clinical trials. Labs/Teams: Leads the Prostate Cancer Research Group at Monash, focusing on integrative oncology research and clinical genomics.

• Musculoskeletal Health
• Pain Management
• Public Health
• +4 more

Margreth Grotle is a Professor at OsloMet – Oslo Metropolitan University, affiliated with the Faculty of Health Sciences and the Department of Rehabilitation Science and Health Technology. Her work focuses on musculoskeletal health, pain management, and clinical prediction models. She leads research projects addressing chronic pain in adolescents, personalized healthcare for spinal disorders, and decision-making processes in spine surgery. Notable projects include the HEYoung intervention study (adolescent pain management) and the AID-Spine initiative (AI-driven healthcare). Her research emphasizes translational studies on musculoskeletal conditions, including modifiable risk factors for healthcare costs, motivational interviewing for return-to-work outcomes, and the societal impact of persistent pain in young adults. She collaborates with interdisciplinary teams and has published extensively in journals like BMC Musculoskeletal Disorders and JAMA Network Open . Key research themes include predictive modeling for musculoskeletal outcomes, healthcare system optimization, and patient-centered interventions. Current projects address barriers to education/employment for pain-affected youth and the role of artificial intelligence in spinal care.

• Prehospital Resuscitation
• Out-of-Hospital Cardiac Arrest
• Emergency Medicine
• +3 more

Betty Yang, MD, MS, is an emergency medicine physician and prehospital researcher affiliated with the University of Texas Southwestern Medical Center. She serves as associate medical director of the UTSW/Parkland BioTel EMS System and cares for patients at Clements University Hospital and Parkland Memorial Hospital. Her research focuses on prehospital resuscitation, particularly out-of-hospital cardiac arrest, ventilation techniques, and trauma care innovation. Dr. Yang holds a master’s degree in Health Systems and Population Health from the UW School of Public Health. She completed EMS and research fellowships at the University of Washington, gaining expertise in quality improvement, pandemic response, and implementation science. Her work integrates clinical practice with translational research, emphasizing novel therapies and evidence-based prehospital care. Her research portfolio includes studies on resuscitation outcomes, temperature management post-cardiac arrest, and ventilation device efficacy. Recent work explores machine learning applications for predicting refractory ventricular fibrillation during cardiac arrest. She has secured funding from the Medic One Foundation and the AHA Strategically Focused Research Network. Awardees include the UT Southwestern Dean’s Scholar in Clinical Research. Dr. Yang collaborates with EMS agencies like Seattle Fire Medic One and King County Public Health, advancing prehospital protocols. She previously served as a flight physician with Airlift Northwest, enhancing her hands-on experience in critical care transport.

• Statistics
• Econometrics
• Biostatistics
• +7 more

Professor Alessio Farcomeni is a distinguished statistician at the University of Rome Tor Vergata, affiliated with the Department of Economics and Finance. His work spans statistical methodology, biostatistics, and applied econometrics. He teaches advanced courses such as Statistical Learning and Big Data Analysis for Economics and Finance , reflecting his expertise in modern data science. His research focuses on latent Markov models, quantile regression, and population size estimation, with applications in healthcare, epidemiology, and policy analysis. Farcomeni has contributed significantly to statistical methodology through publications in high-impact journals. Notable projects include modeling the Italian response to the Covid-19 pandemic, analyzing atrial fibrillation risk prediction, and developing Bayesian approaches for complex datasets. His work often bridges theoretical statistics with real-world challenges, such as optimizing treatment protocols for cancer patients and evaluating macroprudential policies. He maintains active collaborations with institutions like the Italian National Health Service and has advised on international studies, including the CALIPSO transplant infection project. His research has addressed critical issues like material deprivation measurement in Europe and the prognosis of metastatic prostate cancer. Farcomeni is recognized for pioneering methods in latent variable modeling and robust statistical inference. His teaching and mentorship are complemented by software development contributions, such as the Qtools package for quantile regression analysis. Despite prolific output, he emphasizes interdisciplinary collaboration, evidenced by his work in cardiology, oncology, and public health.

• Predictive Maintenance
• Explainable Artificial Intelligence (XAI)
• Data Mining
• +5 more

YOUNESS Genane is an Associate Professor affiliated with CESI's Engineering and Numerical Tools Research team. He has held roles including ex-Head of the Statistics Department at CNAM-Lebanon (2004-2021) and is currently an associate researcher at the MSDMA laboratory (CEDRIC-CNAM). His expertise spans Predictive Maintenance, Explainable AI, and advanced statistical methodologies. Education: PhD in Statistics (Pierre & Marie Curie University, 2004), DEA in Statistics (2000), Master of Applied Mathematics (Lebanese University, 1997) Research interests focus on failure prognosis through data-driven approaches, trust in AI systems, and partition comparison techniques in machine learning. Recent work emphasizes XAI's role in predictive maintenance and bias mitigation in AI models. Publications span over 20 years, with recent contributions exploring LSTM complexity effects on XAI, grid search optimization for MLP, and organizational culture impacts on mobility behaviors. Awards: HCIA-AI Huawei Certification (2020), Huawei ICT Academy Instructor (2020) Supervision includes PhD candidates Lamine NDAO (XAI fairness) and Lola JOLY (higher education culture analysis), alongside master’s internships on PHM and hyperparameter optimization. He has contributed to European-funded projects like Conecte and FAO's Lebanon National Forest Assessment. Expertise includes R training for digital transition initiatives and data analysis for Lebanese institutions. Active reviewer for RJCIA-PFIA and Communications in Statistics.

Jason TarkinView profile

Research Fellow

• Cardiovascular Imaging
• Atherosclerosis
• Inflammatory Cardiovascular Disease
• +4 more

Dr. Jason Tarkin is a Wellcome Clinical Research Career Development Fellow and Associate Principal Investigator at the Victor Phillip Dahdaleh Heart & Lung Research Institute, University of Cambridge. He holds dual appointments as an Honorary Consultant Cardiologist at Cambridge University Hospitals NHS Trust with an imaging sub-specialty and as a Junior Research Fellow at St Catharine’s College, Cambridge. His leadership extends to key roles in the British Society of Cardiovascular Imaging Executive Committee, British Heart Foundation Clinical Research Collaborative Steering Committee, UK CARDIO-IMID Network Steering Committee, and the Editorial Board for Circulation Cardiovascular Imaging . Dr. Tarkin earned summa cum laude with honors in Biology from the University of New Hampshire (2003), graduated with Distinction in Medicine from St. George's, University of London (2008), and completed his PhD at the University of Cambridge (2017). His clinical training spanned Barts Heart Centre, Hammersmith Hospital (as NIHR Clinical Lecturer at the National Heart & Lung Institute), and Addenbrooke’s Hospital. His research pioneers multi-modality imaging approaches to quantify inflammatory disease activity in atherosclerosis and cardiovascular conditions through somatostatin receptor PET/MR imaging. Current projects focus on tracking cardiovascular inflammation as a prognostic marker for plaque progression and ventricular remodeling post-MI (NCT04073810), diagnostic/therapeutic monitoring in vasculitis (NCT04071691), and drug efficacy assessment in hyperlipidemia (NCT04073797). The collaborative PLAK-TALK study investigates intercellular communication pathways linking molecular mechanisms to clinically measurable biomarkers. Analysis of Dr. Tarkin's 15 most recent publications reveals a dominant focus on inflammatory phenotyping in cardiovascular disease using advanced imaging modalities. Key trends include PET/MR applications for vascular inflammation quantification, machine learning integration for plaque characterization, and translational studies connecting imaging biomarkers to clinical outcomes in immune-mediated diseases. His work consistently bridges molecular mechanisms with clinical applications across atherosclerosis, vasculitis, and post-infarction remodeling. American Heart Association Melvin Judkin’s Young Investigator Award (2016) American College of Cardiology William W Parmley Young Author Achievement Award (2018) Wellcome Clinical Research Career Development Fellowship Dr. Tarkin leads a research group comprising Dr. Andrej Ćorović, Dr. Christopher Wall, and Dr. Marta Peverelli, with collaborations spanning Prof. James Rudd, Prof. Ziad Mallat, Dr. Meritxell Nus, Dr. Helle Jørgensen, and Dr. Nicholas Evans. His work is supported by Wellcome Trust funding and clinical trial grants (NCT identifiers), focusing on therapeutic monitoring and diagnostic innovation. The group operates within the Victor Phillip Dahdaleh Heart & Lung Research Institute's Clinical Research Facility, utilizing hybrid PET/MR imaging capabilities and molecular profiling platforms to investigate inflammatory cardiovascular phenotypes.

Emma VerelstView profile

Academic

• Medical Physics
• Radiology
• Photon-counting CT
• +5 more

Emma Verelst is a doctoral student at the Faculty of Medicine and Pharmacy , Vrije Universiteit Brussel , and a Medical Physicist Expert. Her research focuses on photon-counting CT , with applications in stent distinction , lung ventilation analysis , and Xenon gas-enhanced imaging . She is affiliated with the Research Centre for Digital Medicine and actively collaborates on projects involving silicon-based CT detectors and contrast media separation . Projects: FWOSB155: Evaluation of regional lung ventilation by Xenon gas-enhanced spectral CT imaging (2023–2027) Research Output Trends: Emma’s work spans medical physics , radiology , and CT imaging , with emphasis on stent visualization , ventilation modeling , and detector technology . Her studies compare photon-counting CT with conventional methods, addressing motion artifacts , contrast separation , and plaque analysis . Key Topics: Photon-counting CT, Stent Imaging, Xenon Gas, Lung Ventilation, CT Phantom Studies, Contrast Media Separation

• Oral Health
• Gut Microbiome
• Nutrition Science
• +8 more

Dr. Thilini Jayasinghe is a Research Fellow at the Sydney Dental School within the Faculty of Medicine and Health at The University of Sydney. She is also a member of the Charles Perkins Centre, where she conducts interdisciplinary research at the intersection of oral health, microbiome science, and nutrition. Her work bridges clinical dentistry with molecular biology and public health approaches to understand the complex relationships between diet, inflammation, and systemic diseases. Education: PhD in Health Sciences, Liggins Institute, The University of Auckland Master of Science in Molecular Bioscience, The University of Sydney Master of Science in Food and Nutrition, Postgraduate Institute of Agriculture, University of Peradeniya, Sri Lanka Bachelor of Science (Hons) in Food Science and Nutrition, Wayamba University, Sri Lanka Dr. Jayasinghe's research primarily focuses on the intricate relationships between the oral and gut microbiome, inflammation, and diet across various diseases such as diabetes mellitus, cardiovascular disease, obesity, and periodontitis. She investigates how oral pathogenic bacteria and inflammatory substances can cross the oral epithelial barrier and enter the bloodstream, leading to systemic inflammation. Her work utilizes infectious mouse models and human experimental gum disease models to understand diet's impact on inflammation. She is actively developing machine learning-based prognostic tools for predicting periodontal disease progression and examining oral health's influence on pregnancy outcomes through the BABY1000 study, which follows pregnant women to explore how the first 1000 days of life might influence long-term health risks for obesity, diabetes, and cardiovascular disease. Her publication record demonstrates a strong focus on the connections between oral health, gut microbiome, and systemic diseases. Recent work has explored cardiovascular medications' effects on microbiome health, dietary protein's impact on periodontal health, and the role of advanced glycation end-products in periodontitis. She has conducted significant research on fecal microbiota transplantation for obesity treatment and has investigated how preterm birth affects gut bacterial populations in children. Her interdisciplinary approach combines molecular biology, microbiology, and nutrition science to address complex health questions. Scientific Awards: Bursary to attend STAMPS at Marine Biological Laboratory (2017) Best short talk at 'Exploring Human Host-Microbiome Interactions' conference (2016) University of Auckland Residential Excellence award (2016, 2015) University of Auckland Doctoral Scholarship (2014) Best Presentation at International Course in Nutrition Research Methods (2014) Group Academic Excellence in 'Health Research Methods' course (2013) Professor HP Gunasena Award for best performance (2008) Dr. Jayasinghe contributes to teaching in the Doctor of Dental Medicine (DMD) program, specifically in Evidence Based Practice, Oral & Systemic Biosciences, DMD research projects, and Treatment Planning. She also teaches human nutrition and microbiology. Her current research projects include investigating maternal oral health and adverse pregnancy outcomes, diet-induced stimulation of gut immune regulatory functions against periodontal disease, and the role of dietary fiber in periodontal disease using infectious mouse models. She received the FMH Bright Ideas Grant in 2023 to support her innovative research. Her work on developing a machine learning-based prognostic tool for predicting periodontal disease progression represents an important intersection of dental science and artificial intelligence. As a member of the Charles Perkins Centre, Dr. Jayasinghe collaborates with multidisciplinary teams focusing on chronic diseases and aging. Her research on oral bacterial translocation in relation to diabetes and cardiovascular diseases provides valuable insights into the oral-systemic connection. Her work with the BABY1000 study positions her at the forefront of understanding how early life factors influence long-term health outcomes, particularly in the context of oral health and its systemic implications.

Benedict MichaelView profile

Professor

• Neurological Infections
• Neuroimmunology
• Neurovirology
• +6 more

Professor Benedict D Michael is a distinguished academic neurologist at the University of Liverpool, where he directs the Brain Infection & Inflammation Group. He holds an MRC Clinician Scientist Fellowship and serves as an Honorary Consultant Neurologist at The Walton Centre NHS Trust. His career spans postdoctoral training at Harvard Medical School and Massachusetts General Hospital, where he pioneered intravital microscopy models of viral encephalitis. Neurological infections Neuroimmunology Neurovirology His research focuses on neuroinflammatory responses to infections, particularly examining cytokine dynamics and blood-brain barrier permeability in encephalitis. He leads the £2.3m UKRI-funded COVID-Clinical Neuroscience Study (COVID-CNS) and has secured over £4.4m as PI across grants. His work extends to developing ClickClinica© , a disease surveillance app, and improving neurological access in sub-Saharan Africa through NeuroACCESS . Scientific accolades include the Royal College of Physicians Linacre Lecture Award (2022) and the British Medical Association Vera Down Award (2016). He chairs Encephalitis International’s Scientific Advisory Panel and contributes to WHO neurological guidelines. His educational initiatives NeuroPACES and NeuroID support clinical neurology training globally.